Melatonin and Cancer Hallmarks

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Melatonin is a hormone produced by the pineal gland, crucial for circadian rhythm regulation.
• Extensive research indicates melatonin possesses anticancer properties against diverse cancer types.
• Cancer is characterized by specific hallmarks, including uncontrolled proliferation and immune evasion.

Purpose of the Study:

• To review and summarize the anticancer effects of melatonin.
• To elucidate how melatonin interferes with established cancer hallmarks.
• To provide a foundation for future clinical and basic research on melatonin's therapeutic potential.

Main Methods:

• Literature review of preclinical and clinical studies on melatonin and cancer.
• Analysis of studies detailing melatonin's impact on cancer hallmarks.
• Synthesis of evidence on melatonin's mechanisms of action in cancer.

Main Results:

• Melatonin demonstrates efficacy against numerous cancer types.
• Melatonin interferes with multiple cancer hallmarks, such as proliferation, angiogenesis, and apoptosis resistance.
• Evidence supports melatonin's role in modulating cellular energetics and immune responses in cancer.

Conclusions:

• Melatonin exhibits broad-spectrum anticancer activity by targeting key cancer hallmarks.
• Further research into melatonin is warranted to explore its clinical application as an anticancer agent.
• Melatonin represents a promising natural compound for cancer therapy development.